MoneyWorks4Me

Aurobindo Pharma informs about earnings call trascript

11 Jun 2021 Evaluate
Aurobindo Pharma has informed that it has enclosed the Transcript of the analyst/ investor call on the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2021 and the same is being uploaded on the website of the Company and is available in the following web link. http://www.aurobindo.com/investors/resuIts-reports-presentations/conference-call-transcripts/

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1661.00 71.50 (4.50%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: